Chesley Taft & Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q3 | – | Sell |
-3,560
| Closed | -$644K | – | 239 |
|
|
2015
Q2 | $644K | Sell |
3,560
-50
| -1% | -$9.05K | 0.07% | 163 |
|
|
2015
Q1 | $626K | Sell |
3,610
-1,693
| -32% | -$294K | 0.06% | 169 |
|
|
2014
Q4 | $981K | Buy |
5,303
+35
| +0.7% | +$6.48K | 0.1% | 142 |
|
|
2014
Q3 | $874K | Hold |
5,268
| – | – | 0.09% | 149 |
|
|
2014
Q2 | $823K | Sell |
5,268
-282
| -5% | -$44.1K | 0.09% | 153 |
|
|
2014
Q1 | $844K | Sell |
5,550
-945
| -15% | -$144K | 0.09% | 153 |
|
|
2013
Q4 | $863K | Hold |
6,495
| – | – | 0.09% | 170 |
|
|
2013
Q3 | $754K | Buy |
6,495
+25
| +0.4% | +$2.9K | 0.08% | 172 |
|
|
2013
Q2 | $597K | Buy |
+6,470
| New | +$597K | 0.07% | 195 |
|